Hot Equities Review & Reports for : (OTCQB : AMBS), (OTCQB : ACTC)
AmarantusBioScience, Inc. (OTCQB: AMBS), a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis centered around its patented anti-apoptosis therapeutic protein MANF, announced that President & CEO Gerald Commissiong will make a corporate presentation at Biotech Showcase 2013 on Wednesday January 9, 2013 at 9:00am PST at the Parc 55 Wyndham Hotel in San Francisco, CA. “The presentations scheduled the week of the healthcare industry’s largest annual congregation of key decision makers in San Francisco will...
View full press release